Estradiol activates p60(src), p53/56(lyn) and renatured p50/55 protein tyrosine kinases in the dog prostate

Molecular and Cellular Endocrinology

Volumn 126, Issue 1, 1997, Pages 25-34

  Allard, Pierre ^a,b   Atfi, Azeddine ^b   Landry, France ^b   Chapdelaine, Alcide ^a   Chevalier, Simone ^a,b,c  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Androgen; Estradiol; Lyn; Prostate; Src; Tyrosine kinases

Indexed keywords

ANDROGEN; ANTIBODY; ESTRADIOL; PROTEIN KINASE P60; PROTEIN P53; PROTEIN TYROSINE KINASE; LYN PROTEIN-TYROSINE KINASE; PROTEIN KINASE LYN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASTRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ESTROGEN THERAPY; GEL FILTRATION CHROMATOGRAPHY; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; SIGNAL TRANSDUCTION; ANIMAL; DOG; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PROTEIN DENATURATION;

ANIMALS; DOGS; ENZYME ACTIVATION; ESTRADIOL; MALE; MOLECULAR WEIGHT; ONCOGENE PROTEIN PP60(V-SRC); PROSTATE; PROTEIN DENATURATION; PROTEIN-TYROSINE KINASES; SRC-FAMILY KINASES;

EID: 0030614384     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(96)03966-4     Document Type: Article

References (37)

1. Wingo P.A., Tong T. and Bolden B. (1995) Cancer statistics, 1995. C.A. Cancer J. Clin. 45, 8-30.
2. Coffey D.S. and Walsh P.C. (1990) Clinical and experimental studies of benign prostatic hyperplasia. Urol. Clin. North Am. 17, 461-475.
3. Ware J.L. (1993) Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev. 12, 287-301.
4. Story M.T. (1994) Positive and negative modulators of prostate cell proliferation. Biomed. Pharmacother. 48, 35s-41s.
5. Scott W.W., Menon M. and Walsch P.C. (1980) Hormonal therapy of prostate cancer. Cancer 45, 1929-1936.
6. Sinowatz F., Amselgruber W., Plendl J., Kölle S., Neumüller C.H. and Boos G. (1995) Effets of hormones on the prostate in adult and aging men and animals. Microsc. Res. Tech. 30, 282-292.
7. Aprikian A.G., Fair W.R., Reuter V.E., Sogani P., Herr H., Russo P. and Sheinfeld J. (1994) Experience with neoadjuvant diethylstilbestrol and radical prostatectomy in locally advanced prostate cancer. Br. J. Urol. 74, 630-636.
8. Deklerk D.P., Coffey D.S., Ewing L.L., McDermott I.R., Reiner W.G., Robinson C.H., Scott W.W., Strandberg J.D., Taladay P., Walsh P.C., Wheaton L.G. and Zirbin B.R. (1979) Comparison of spontaneous and experimentally induced canine prostatic hyperplasia. J. Clin. Invest. 64, 842-849.
9. Merk F.B., Ofner P., Kwan P.W.L., Leav I. and Vena R.L. (1982) Ultrastructural and biochemical expressions of divergent differentiation in prostates of castrated dogs treated with estrogen and androgen. Lab. Invest. 47, 437-450.
10. Landry F., Chapdelaine A., Begin L.R. and Chevalier S. (1996) Phosphotyrosine antibodies preferentially react with basal epithelial cells in the dog prostate. J. Urol. 155, 386-391.
11. Panayotou G. and Waterfield M.D. (1993) The assembly of signalling complexes by receptor tyrosine kinases. BioEssays 15, 171-177.
12. Malarkey K., Belham C.M., Paul A., Graham A., McLees A., Scott P.H. and Plevin R. (1995) The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors. Biochem. J. 309, 361-375.
13. Rodrigues G.A. and Park M. (1994) Oncogenic activation of tyrosine kinases. Curr. Opin. Genet. Dev. 4, 15-24.
14. c-src family of protein-tyrosine kinases. Int. J. Biochem. Cell. Biol. 27, 551-563.
15. Atfi A., Drobetsky E., Boissonneault M., Chapdelaine A. and Chevalier S. (1994) Transforming growth factor β down-regulates Src family protein tyrosine kinase signaling pathways. J. Biol. Chem. 269, 30688-30693.
16. Nguyen L.T., Beauregard G., Tessier S., Allard P., Atfi A., Durocher Y., Chapdelaine A., Potier M. and Chevalier S. (1996) Radiation inactivation and in situ renaturation of protein tyrosine kinases reveal a major 50-kDa enzyme as part of a membrane complex present in dividing but not in resting prostatic epithelial cells. Biochem. Cell. Biol. 74, 75-85.
17. O'Shea J.D. (1962) Studies on the canine prostate gland. J. Comp. Pathol. 72, 321-331.
18. Merk F.B., Warhol M.J., Kwan P.W.L., Leav I., Alroy J., Ofner P. and Pinkus G.S. (1986) Multiple phenotypes of prostatic glandular cells in castrated dogs after individual or combined treatment with androgen and estrogen. Lab. Invest. 54, 442-457.
19. Isaacs W.B. and Shaper J.H. (1983) Isolation and characterization of the major androgen-dependent glycoprotein of canine prostatic fluid. J. Biol. Chem. 258, 6610-6615.
20. Shah I.A., Schlageter M.O., Stinnet P. and Lechago J. (1991) Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from epithelial lesions of the prostate. Mod. Pathol. 4, 220-224.
21. Bourassa C., Nguyen L.T., Roberts K. and Chevalier S. (1991) Characterization of protein-tyrosine kinase activity in the canine prostate. Biochem. Cell. Biol. 69, 146-153.
22. Bradford M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
23. Durocher Y., Chapdelaine A. and Chevalier S. (1992) Identification of cytosolic protein tyrosine kinases of human prostate by renaturation after SDS/PAGE. Biochem. J. 284, 653-658.
24. Stanley E., Ralph S., McEwen S., Boulet I., Holtzman D.A., Lock P. and Dunn A.R. (1991) Alternative spliced murine lyn mRNAs encode distinct proteins. Mol. Cell. Biol. 11, 3399-3406.
25. src is an endogenous substrate for calpain in human blood platelets. J. Biol. Chem. 268, 12603-12608.
26. c-src function. J. Biol. Chem. 264, 20886-20893.
27. Silverman L., Sudol M. and Resh M.D. (1993) Members of the src family of nonreceptor tyrosine kinases share a common mechanism for membrane binding. Cell Growth Differ. 4, 475-482.
28. Chevalier S., McKercher G. and Chapdelaine A. (1991) Serum and prostatic growth promoting factors for steroid independent epithelial cells of adult dog prostate. Prostate 19, 207-220.
29. Ehara H., Koji T., Deguchi T., Yoshii A., Nakano M., Nakahe P.K. and Kawada Y. (1995) Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry. Prostate 27, 304-313.
30. Kirschenbaum A., Ren M., Erenburg I., Schachter B. and Levine A.C. (1994) Estrogen receptor messenger RNA expression in human benign prostatic hyperplasia: Detection, localization, and modulation with a long-acting gonadotropin-releasing hormone agonist. J. Androl. 15, 528-533.
31. Ehrlichman R.J., Isaacs J.T. and Coffey D.S. (1981) Differences in the effects of estradiol on dihydrotestosterone induced prostatic growth of the castrate dog and rat. Invest. Urol. 18, 466-470.
32. Yamamoto T., Yumanashi Y. and Toyoshima K. (1993) Association of Src-family kinase Lyn with B-cell antigen receptor. Immunol. Rev. 132, 187-206.
33. 1b in rat basophilic leukemia RBL-2H3 cells. J. Biol. Chem. 269, 5249-5254.
34. Chevalier S., Aprikian A.G., Beauregard G., Defoy I. and Nguyen L. (1996) Action, localization and structure-function relationship of growth factors and their receptors in the prostate. Reprod. Med. Rev. In press.
35. Tremblay L., Hauck W., Nguyen L.T., Allard P., Landry F., Chapdelaine A. and Chevalier S. (1996) Regulation and activation of focal adhesion kinase and paxillin during the adhesion, proliferation, and differentiation of prostatic epithelial cells in vitro and in vivo. Mol. Endocrinol. 10, 1010-1020.
36. Bonkhoff H. and Remberger K. (1996) Differentiation pathways and histogenetic aspect of normal and abnormal prostatic growth: A stem cell model. Prostate 28, 98-106.
37. Durocher Y., Chapdelaine A. and Chevalier S. (1989) Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines PC3 and DU145. Cancer Res. 49, 4818-4823.